Idera Pharmaceuticals

We are a biotechnology company engaged in the discovery and development of novel therapeutics that modulate immune responses through Toll-like receptors (TLR) for the treatment of multiple diseases.Idera Pharmaceuticals’ business strategy is to advance its clinical-stage cancer programs and to develop other applications of its technology through new partnerships. We currently are collaborating with Novartis to develop treatments for asthma and allergy indications

Contact Details: 345 Vassar Street Cambridge Massachusetts 02139 United States of America Tel: (617) 679-5500 Fax: (617) 679-5592 Email: info@iderapharma.com WWW: www.iderapharma.com/

Loading...

Recent Publications by Idera Pharmaceuticals:
Synthetic agonists of Toll-like receptors 7, 8 and 9. TLRs (Toll-like receptors) are a family of innate immune receptors that...	20th March, 2008	Idera Pharmaceuticals, 167 Sidney Street, Cambridge, MA 02139, USA.	Biochem Soc Trans. 2007 Dec;35(Pt 6):1461-7. DOI Direct Link
Agonists of Toll-like receptor 9 containing synthetic dinucleotide motifs. Oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs activate...	11th March, 2008	Idera Pharmaceuticals, Inc., 167 Sidney Street, Cambridge, Massachusetts	J Med Chem. 2007 Dec 13;50(25):6411-8. Epub 2007 Nov 8. DOI Direct Link
Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice. BACKGROUND: Agonists of Toll-like receptor 9 have been shown to induce...	8th November, 2007	Idera Pharmaceuticals, Inc, Cambridge, Mass, USA.	J Allergy Clin Immunol. 2007 Sep;120(3):631-7. Epub 2007 Jun 20. DOI Direct Link
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8. Viral and synthetic single-stranded RNAs are the ligands for Toll-like...	20th October, 2007	Idera Pharmaceuticals, Inc., 167 Sidney Street, Cambridge, MA 02139, USA.	Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13750-5. Epub 2007 Aug 14. DOI Direct Link
Novel oligodeoxynucleotide agonists of TLR9 containing N3-Me-dC or N1-Me-dG modifications. Synthetic oligodeoxynucleotides containing unmethylated CpG motifs...	13th July, 2006	Idera Pharmaceuticals, Inc. 345 Vassar Street, Cambridge, MA 02139, USA.	Nucleic Acids Res. 2006 Jun 23;34(11):3231-8. Print 2006. DOI Direct Link
→View more Idera Pharmaceuticals research publications.

BioNews Results for Idera Pharmaceuticals:
BUYINS.NET: IDRA, RICK, DIAAF, SKNN, XHUA, ORXGF Have Also Been Added To Naked Short List Today	Calibre Macro World:  Aug 25 2008 12:39PM Matching: idera pharmaceuticals
Idera Pharmaceuticals Inc (NASD:IDRA) Weekly Earnings Information	Evergreen Investments:  Aug 24 2008 6:32AM Matching: idera pharmaceuticals
Idera Pharmaceuticals Inc(GAAP) (IDRA.GP) Weekly Earnings Information	Evergreen Investments:  Aug 24 2008 6:32AM Matching: idera pharmaceuticals
BUYINS.NET: BWTR, CHTT, ICXT, IDRA, PHHM, SNIC Have Also Been Removed From Naked Short List Today	TMC Net:  Aug 12 2008 6:38PM Matching: idera pharmaceuticals
Canaccord Capital Corp Changes EPS Estimate of IDERA PHARMACEUTICALS INC: Current Recommendation is Hold	Macro World Investor:  Aug 9 2008 12:11AM Matching: idera pharmaceuticals
Promote your company here: BioNewsCast - Press Release Distribution	→View more Idera Pharmaceuticals news.

Idera Pharmaceuticals Patents:
US Patent No.	Title
7407944	Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
7105495	Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
7115579	Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
7173014	HIV-specific synthetic oligonucleotides and methods of their use
7176296	Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides
→View more Idera Pharmaceuticals patents.

Idera Pharmaceuticals (IDP) Financial information Links from Barchart
IDP Quote from from Barchart.com
IDP Chart from from Barchart.com
IDP Profile from from Barchart.com
IDP Opinion from from Barchart.com
→View more Idera Pharmaceuticals finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 268 times since April 2007, the link to the organisation's website has been followed 38 times

Recent Search Terms used to find this page: Biochem Soc Trans. 2007 Dec 35 Pt 6 1461-7 | .

Search for more companies in Cambridge

Search for more companies in Massachusetts

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Idera Pharmaceuticals